Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 120, Issue 12, Pages 4532-4545Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI43961
Keywords
-
Categories
Funding
- NIH [1R01AI083201-01, 1R01NS065845-01]
- National Foundation for Science, Higher Education and Technological Development of the Republic of Croatia [04/16]
- S Jonjic and Croatian Ministry for Science and Technology [0621261-1268]
- Howard Hughes Medical Institute
Ask authors/readers for more resources
Human CMV (HCMV) is a major cause of morbidity and mortality in both congenitally infected and immunocompromised individuals. Development of an effective HCMV vaccine would help protect these vulnerable groups. NK group 2, member D (NKG2D) is a potent activating receptor expressed by cells of the innate and adaptive immune systems. Its importance in HCMV immune surveillance is indicated by the elaborative evasion mechanisms evolved by the virus to avoid NKG2D. In order to study this signaling pathway, we engineered a recombinant mouse CMV expressing the high-affinity NKG2D ligand RAE-1 gamma (RAE-1 gamma MCMV). Expression of RAE-1 gamma by MCMV resulted in profound virus attenuation in vivo and lower latent viral DNA loads. RAE-1 gamma MCMV infection was efficiently controlled by immunodeficient hosts, including mice lacking type I interferon receptors or immunosuppressed by sublethal gamma-irradiation. Features of MCMV infection in neonates were also diminished. Despite tight innate immune control, RAE-1 gamma MCMV infection elicited strong and long-lasting protective immunity. Maternal RAE-1 gamma MCMV immunization protected neonatal mice from MCMV disease via placental transfer of antiviral Abs. Despite strong selective pressure, the RAE-1 gamma transgene did not exhibit sequence variation following infection. Together, our results indicate that use of a recombinant virus encoding the ligand for an activating NK cell receptor could be a powerful approach to developing a safe and immunogenic HCMV vaccine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available